The aforementioned literature review by Sinha et al
medical centers says the offending ingredient is L-carnitine, a compound that is abundant in red meat
Switching to an alternative (non glp-1) anti obesity medication The Approach Switching to a non GLP-1 anti obesity medication means replacing the GLP-1 with another approved weight loss medicine to help maintain weight loss
Global GLP-1 use is projected to top 100 million people by 2030
Significant healing improvements develop over four to six weeks with consistent use
Perspectives There are concerns that consumption of red meat increases risks for chronic diseases or metabolic disorders in humans, including obesity, type II diabetes mellitus, cardiovascular disease (the number one killer in the developed nations), ageing-related dysfunction and atrophy of organs (particularly, the brain and skeletal muscle), and cancers (Willet et al